Telehealth firm Hims & Hers Health said on Monday it plans to bring a generic version of Novo Nordisk's diabetes drug, liraglutide, to its platform in 2025.
Philadelphia Inquirer on MSN18h
Pa., N.J. join settlement with generic drug firms accused of price-fixing. Consumers may be eligible for refunds.A coalition of state attorneys general, including those in Pennsylvania and New Jersey, has reached agreements with two ...
These drugs are collectively known as GLP-1 agonists because they mimic the body’s natural hormone GLP-1, which regulates ...
Telehealth company Hims & Hers said late Monday in an earnings update that it plans to launch a generic version of Novo ...
In a world where weight management is increasingly prioritized, appetite suppressants have gained immense popularity for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback